We provide the information on this website for free. Please take out a membership with TSA so we can continue to do so.

Search

Book a call with our Nurse Donate

Understanding TSC
Find Support
Support Us
For Health Care Professionals
About Us/Contact Us

Book a call with our Nurse Donate

Understanding TSC
Find Support
Support Us
For Health Care Professionals
About Us/Contact Us

The EPISTOP study

19 Apr 2021 - < 1 min read - Share on Facebook, LinkedIn or by email.

Quicklinks

Connect with our Nurse
Diagnostic Criteria
Events
Genetics and TSC
Resources
Signs, Symptoms and Treatments
Surveillance and Screening
Join us

TSA acknowledges Aboriginal and Torres Strait Islander people as the traditional custodians of the lands on which we live and work and values their cultural knowledge, strength and resilience. We pay respect to Elders, past, present and emerging and to the Aboriginal and Torres Strait Islander people in our Community.

Tuberous Sclerosis Australia Inc. is an incorporated association under New South Wales law. You can download and read our Constitution here. We are registered with the Australian Charities and Not-for-profits Commission (ACNC).
Disclaimer: The information on this website is intended to provide basic information about Tuberous Sclerosis Complex (TSC). It is not intended to, and it should not, constitute medical or other advice. Readers are warned not to take any action without first seeking medical advice. The TSA Privacy Policy explains how we handle your personal information.
Thank you to our supporters. TSA receives no ongoing government funding and relies on your generosity. All donations $2 and over are tax deductible.

Registered Charity CC25313
Incorporation number Y07116-42
ABN 20 681 174 734
Site by Marlin | A Strategy, Creative, Digital Agency

Phone:	1300 733 435 (Australia only)
Email:	[email protected]
Address:	TSA (Tuberous Sclerosis Australia) 18 Central Road Beverly Hills NSW 2209 Australia

Quicklinks

Related articles

Have you heard of diagnostic overshadowing?

TSC research trial still recruiting in Australia

The BEYOND Clinical Trial investigating the effects of Cannabidiol on seizure outcomes is now recruiting in NSW and Canberra